The aim of this preliminary study was to define the prevalence and clinical significance of Ki-67 and Cyclin D1 overexpression in primary ER positive invasive breast cancer, while highlighting the existence of intratumor heterogeneity in this type of cancer. This evidence concerns the gene CCND1 and cancer.